Bliss GVS Pharma Limited (NSE:BLISSGVS)
India · Delayed Price · Currency is INR 236.50
+2.32 (0.99%)
Apr 6, 2026, 3:30 PM IST
Bliss GVS Pharma Employees
Bliss GVS Pharma had 966 employees as of March 31, 2025. The number of employees increased by 135 or 16.25% compared to the previous year.
Employees
966
Change (1Y)
135
Growth (1Y)
16.25%
Revenue / Employee
8.99M INR
Profits / Employee
1.13M INR
Market Cap
25.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 966 | 135 | 16.25% |
| Mar 31, 2024 | 831 | 68 | 8.91% |
| Mar 31, 2023 | 763 | 13 | 1.73% |
| Mar 31, 2022 | 750 | 67 | 9.81% |
| Mar 31, 2021 | 683 | 20 | 3.02% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,775 |
| Jagsonpal Pharmaceuticals | 1,399 |
| Windlas Biotech | 1,346 |
| RPG Life Sciences | 1,331 |
| Ind-Swift Laboratories | 1,246 |
| Orchid Pharma | 736 |
| Beta Drugs | 399 |
Bliss GVS Pharma News
- 5 months ago - Bliss GVS Pharma shares fall over 15% today as EBITDA drops 20% and margins shrink to 13% - Business Upturn
- 5 months ago - Bliss GVS Pharma Q2 results: Net profit up 2.5% to Rs 25.69 crore; EBITDA down 20%, margin contracts to 13% - Business Upturn
- 1 year ago - Bliss GVS Clarifies USFDA ANDA Approval for Mesalamine Suppositories - Business Upturn
- 1 year ago - Bliss GVS Pharma shares surge 4% after company receives GMP Compliance certification for its manufacturing facilities in Palghar - Business Upturn
- 1 year ago - Bliss GVS Pharma receives GMP Compliance certification for manufacturing facilities in Palghar, Maharashtra - Business Upturn